5 completed, 1 unknown. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Unknown 1 |
Follow Acute Bronchitis: new trials by email Literature Review of Acute Bronchitis trials Research Report on Acute Bronchitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis ALC-2203-1, ALC-2203-2, ALC-2203-AC - Acute Bronchitis | Phase 2 | Completed | Korea Arlico Pharm. Co., Ltd | 169 | 2025-04-23 | 2025-12-24 |
| Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis GHX02, Placebo - Acute Bronchitis | Phase 2 | Unknown | Daejeon University | 150 | 2019-03-18 | 2019-03-05 |
| A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients HL301, HL301(Placebo) - Acute Bronchitis | Phase 2 | Completed | Hanlim Pharm. Co., Ltd. | 168 | 2017-03-29 | 2017-10-16 |
| Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis N02RS1 1200mg, Placebo - Acute Bronchitis | Phase 2 | Completed | PharmaKing | 108 | 2015-12-01 | 2016-03-30 |
| A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on) HL301 300mg capsule, Placebo - Acute Bronchitis, Acute Exacerbations of Chronic Bronchitis | Phase 2 | Completed | Hanlim Pharm. Co., Ltd. | 156 | 2014-03-01 | 2014-09-26 |
| Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis YHD001 dose level 1, YHD001 dose level 2, Pelargonium sidoides extract - Acute Bronchitis, Chronic Bronchitis | Phase 2 | Completed | Yuhan Corporation | 118 | 2011-09-01 | 2013-09-26 |
Bronchitis (6) · Bronchitis, Chronic (1)
Bronchial Diseases (6) · Infections (6) · Lung Diseases (6) · Lung Diseases, Obstructive (6) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (6) · Chronic Disease (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pulmonary Disease, Chronic Obstructive (1)
microcrystalline cellulose (1)
Hanlim Pharm. Co., Ltd. (2) · Daejeon University (1) · Korea Arlico Pharm. Co., Ltd (1) · PharmaKing (1) · Yuhan Corporation (1)
South Korea (5)
Young Kyoon Kim, M.D., Ph.D. (1)